Ellington Management Group’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,100
Closed -$104K 533
2019
Q3
$104K Buy
+14,100
New +$104K 0.02% 530